Yu Sha, Chen Siyu, Dang Yuan, Zhou Yuanzhen, Zhu Jun-Jie
School of Chemistry and Chemical Engineering, Xi'an University of Architecture and Technology, Xi'an 710055, P. R. China.
State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, P. R. China.
Anal Chem. 2022 Oct 18;94(41):14349-14357. doi: 10.1021/acs.analchem.2c03015. Epub 2022 Oct 3.
Specific and sensitive microRNAs (miRNAs) detection is essential to early cancer diagnosis. The development of these technologies including functional nuclease-mediated target amplification and DNA nanotechnology possesses tremendous potential for the high-performance detection of miRNAs in the accurate diagnosis of disease. In this study, we have established an ultrasensitive electrochemical biosensor by combining nicking endonuclease-assisted primer exchange reaction (PER) cascade amplification with a DNA nanosphere (DNS)-mediated electrochemical signal-enhanced system for the detection of miRNA-21 (miR-21). The cascade amplification is initiated by a nicking endonuclease that can cleave specific DNA substrates and highly amplify translation of the target to single-stranded DNA fragments (sDNA). Then, the PER cascade is powered by strand-displacing polymerase and generates a large amount of nascent single-stranded connector DNA (cDNA) via sDNA triggering of the dumbbell probe (DP), thus achieving the cascade amplification of the target. Finally, the DNS loaded with plenty of electroactive substances can be captured on the electrode via cDNA for further enhancing the electrochemical signal and highly sensitive detection of miR-21. The proposed electrochemical biosensor exhibits a wide detection range of 1 aM to 0.1 nM and a low detection limit of 0.58 aM. The excellent selectivity allows the biosensor to discriminate miR-21 from other miRNAs, even the one base-mismatched sequence. Moreover, the practicability of the biosensor is investigated by analyzing miR-21 in human serum and cancer cell lysate. Therefore, our proposed nicking endonuclease-assisted PER cascade amplification strategy provides a powerful platform for the early detection of miRNA-related disease and molecular diagnosis.
特异性和灵敏的微小RNA(miRNA)检测对于癌症早期诊断至关重要。包括功能性核酸酶介导的靶标扩增和DNA纳米技术在内的这些技术的发展,在疾病的准确诊断中对miRNA进行高性能检测具有巨大潜力。在本研究中,我们通过将切口内切核酸酶辅助的引物交换反应(PER)级联扩增与DNA纳米球(DNS)介导的电化学信号增强系统相结合,建立了一种超灵敏的电化学生物传感器,用于检测miRNA-21(miR-21)。级联扩增由切口内切核酸酶启动,该酶可切割特定的DNA底物并将靶标高度扩增为单链DNA片段(sDNA)。然后,PER级联由链置换聚合酶驱动,并通过哑铃探针(DP)的sDNA触发产生大量新生的单链连接子DNA(cDNA),从而实现靶标的级联扩增。最后,负载有大量电活性物质的DNS可通过cDNA捕获在电极上,以进一步增强电化学信号并实现对miR-21的高灵敏度检测。所提出的电化学生物传感器具有1 aM至0.1 nM的宽检测范围和0.58 aM的低检测限。出色的选择性使生物传感器能够区分miR-21与其他miRNA,甚至是一个碱基错配的序列。此外,通过分析人血清和癌细胞裂解物中的miR-21来研究生物传感器的实用性。因此,我们提出的切口内切核酸酶辅助的PER级联扩增策略为miRNA相关疾病的早期检测和分子诊断提供了一个强大的平台。